Here, we demonstrate efficacy of the estradiol-derived TRPML1 antagonist EDME and analogs, which were rationally designed based on a profound SAR analysis of numerous tested steroidal compounds, on autophagy and TFEB translocation as well as breast cancer cell migration and invasion. Here, TFEB is linked to breast carcinoma.